Masuta, Pardeep <br/><br/>
SGLT2 Inhibitors and Euglycemic Ketoacidosis.  [electronic resource] 

 -  American journal of therapeutics   
 - e498-e500 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1536-3686 
<br/><br/><label>Standard No.: </label>10.1097/MJT.0000000000000587  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--analysis<br/>Canagliflozin--adverse effects<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Ketoacidosis--blood<br/>Female<br/>Glucose--administration & dosage<br/>Humans<br/>Insulin--therapeutic use<br/>Middle Aged<br/>Sodium-Glucose Transporter 2 Inhibitors--adverse effects